How/when will pharmacogenomics translate into improved clinical care?- David Haas, MD

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018

Protecting Women Through Research, Not From Research - Vanessa Apea.pdf

2nd African Workshop on Women & HIV 2025

Hepatitis B virus infection in HIV-seronegative and HIVseropositive MSM in West Africa: prevalence, associated factors, and acceptability of vaccination (CohMSM ANRS 12324 – Expertise France)- T.T.E. Dah

INTEREST 2017

Prof. Valentina Svicher - Andrea del Luca Lecture

European Meeting on HIV & Hepatitis 2021

Next generation sequencing for routine HIV-1 resistance genotyping in a clinical laboratory: unsolved issues

European Meeting on HIV & Hepatitis 2020

Polymorphisms of nr1i2 and nr1i3 - L. Mbatchi

International Workshop on Dose Optimization Strategies for Targeted Drugs – Focus on Oncolytics 2015

Falls and Fractures in HIV_Prevention and Treatment - Todd Brown, MD, PhD

International Workshop on HIV & Aging 2020

NAFLD in HIV- infected patients- Juan Macías, MD, PhD

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

TDF Use Across the Age Spectrum: From Fetus to Adolescent - Anna Turkova, MD

International Workshop on HIV & Pediatrics 2015

Remdesivir — What do the Clinical Trials Tell Us - Daniel Kuritzkes, MD

COVID-19 Online Educational Program 2020